Tag: biotech ingredient market share

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Biotech Ingredient Market Forecast: Value Set To Climb From $67.42 Billion To $87.05 Billion

The biotech ingredient market has experienced significant expansion in recent years. This market is set to increase from $63.25 billion in 2025 to $67.42 billion in 2026, registering a compound annual growth rate (CAGR) of 6.6%. Historical growth can be ascribed to a rising need for natural and secure ingredients, advancements in microbial fermentation technologies, heightened understanding of biotech uses in food and personal care, growing consumer preference for sustainable ingredients, and the initial integration of yeast- and algae-based compounds.

The biotech ingredient market is projected for significant expansion over the coming years, reaching $87.06 billion in 2030 with a compound annual growth rate (CAGR) of 6.6%. This anticipated growth is driven by several factors, such as the increasing scope of precision medicine and personalized nutrition, enhanced government backing for biotech research and development, the scaling up of microbial and yeast expression systems, the integration of artificial intelligence and automation into production, and the expanding application across cosmetics, cleaning products, and food industries. Prominent trends for the forecast period include advancements in synthetic biology, innovations in microbial engineering, the development of cost-effective ingredient production methods, strict adherence to regulatory compliance and safety standards, and wider adoption in food, personal care, and cleaning applications.

Get A Free Sample Report With In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9817&type=smp&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Biotech Ingredient Market Growth Factors: What’s Supporting Expansion?

The future expansion of the biotech ingredient market is anticipated due to the rising need for personal care items. These products encompass a wide range of goods utilized for personal cleanliness and aesthetic improvement. When incorporated into personal care formulations, biotechnologically derived components provide numerous benefits, including a smaller environmental impact, sustainability, uniform quality, lower risk of allergic reactions, better compatibility with biological systems, improved effectiveness, and a decreased reliance on petroleum-based chemicals. As an illustration, the Bureau of Labor Statistics, a US-based government agency, reported in December 2024 that the average yearly spending on personal care goods and services per consumer unit increased from $866 in 2022 to $950 in 2023. Consequently, the growing consumer requirement for personal care items is fueling the expansion of the biotech ingredient market.

Biotech Ingredient Market Segment Landscape: Which Areas Lead Development?

The biotech ingredient market covered in this report is segmented –

1) By Type: Active Pharmaceutical Ingredients, Biosimilars

2) By Expression Systems: Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, Insect Expression Systems

3) By Application: Food And Beverages, Personal Care And Cosmetics, Cleaning Products, Other Applications

Subsegments:

1) By Active Pharmaceutical Ingredients (APIs): Biologic APIs, Synthetic APIs

2) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Insulin Biosimilars

Biotech Ingredient Market Industry Trends: What’s Reshaping Demand?

Leading companies in the biotech ingredient market are concentrating on developing inventive solutions, such as advanced biotechnology-based ingredient platforms, to meet the increasing demand for high-performance, sustainable, and next-generation cosmetic and personal care formulations. These biotechnology-driven ingredients harness enzymatic and bio-based processes to create novel molecular structures with enhanced functionality, providing superior performance, scalability, and environmental benefits compared to traditional chemically synthesized ingredients. For instance, in March 2023, International Flavors & Fragrances Inc., a US-based manufacturer of fragrance, biotech solutions, cosmetic energetics, and organic health ingredients, introduced Aurist AGC, a new biopolymer for hair care. This showcases the potential of the new DEB platform by utilizing IFF’s comprehensive biotechnology functionality to ensure sustained and high-performance glamour solutions that can truly contribute to change in the cosmeceutical industry. The ingredient incorporates IFF’s proprietary Designed Enzymatic Biopolymers (DEB) technology, an advanced biotechnology capable of producing novel bio-based polysaccharides with distinct structures and product features.

Biotech Ingredient Market Industry Leaders And Competitive Landscape

Major companies operating in the biotech ingredient market are Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc.

View The Full Biotech Ingredient Market Report:

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Biotech Ingredient Market Largest Region: Which Geography Holds The Highest Market Share?

Europe was the largest region in the biotech ingredient market in 2025. Asia-Pacific is expected to be the fastest-growing region in the biotech ingredients market report during the forecast period. The regions covered in the biotech ingredient market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Biotech Ingredient Market Size Forecast: How Large Could The Market Become By 2030?

The biotech ingredient sector has seen robust expansion over recent years, with projections showing an increase from $63.25 billion in 2025 to $67.42 billion in 2026—representing a compound annual growth rate (CAGR) of 6.6%. This historical growth has been driven by a rising need for natural and safe components, progress in microbial fermentation methods, heightened understanding of biotechnology’s role in food and personal care products, a growing consumer shift toward sustainable options, and the initial uptake of compounds derived from yeast and algae.

The biotech ingredient market is anticipated to experience robust expansion over the coming years, with projections indicating a rise to $87.06 billion by 2030 at a compound annual growth rate of 6.6%. This forecasted growth is driven by factors such as the widening scope of precision medicine and personalized nutrition, enhanced governmental backing for biotech research and development, the upscaling of microbial and yeast expression systems, the integration of artificial intelligence and automation into manufacturing processes, and an increasing range of uses in sectors like cosmetics, cleaning products, and food. Key trends influencing this period include progress in synthetic biology, breakthroughs in microbial engineering, more cost-efficient methods for producing ingredients, a stronger focus on regulatory compliance and safety protocols, and a broader adoption within the food, personal care, and cleaning industries.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9817&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Biotech Ingredient Market Growth Momentum: Which Factors Are Influencing Demand?

The biotech ingredient market is set to expand further, fueled by an escalating demand for personal care products. These products encompass a wide array of items designed to uphold personal hygiene and improve appearance. The incorporation of biotech ingredients into such products provides numerous advantages, including a smaller environmental footprint, sustainability, dependable uniformity, decreased allergenic potential, biocompatibility, better efficacy, and a lower reliance on petrochemicals. As an illustration, the Bureau of Labor Statistics, a US governmental agency, reported in December 2024 that the typical yearly expenditure on personal care items and services increased from $866 per consumer unit in 2022 to $950 per consumer unit in 2023. Consequently, the rising need for personal care items is propelling the expansion of the biotech ingredient market.

Biotech Ingredient Market Segment Outlook: Which Categories Are Expanding The Fastest?

The biotech ingredient market covered in this report is segmented –

1) By Type: Active Pharmaceutical Ingredients, Biosimilars

2) By Expression Systems: Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, Insect Expression Systems

3) By Application: Food And Beverages, Personal Care And Cosmetics, Cleaning Products, Other Applications

Subsegments:

1) By Active Pharmaceutical Ingredients (APIs): Biologic APIs, Synthetic APIs

2) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Insulin Biosimilars

Biotech Ingredient Market Trends Reshaping Industry Growth

Key industry players within the biotech ingredient space are concentrating on the creation of advanced solutions, such as cutting-edge platforms built on biotechnology, to address the growing need for high-performance, sustainable, and next-generation formulas in cosmetics and personal care. These biotechnology-derived components employ enzymatic and bio-based methods to generate unique molecular architectures with improved capabilities, delivering superior functionality, scalability, and ecological advantages over conventional chemically produced alternatives. In March 2023, International Flavors & Fragrances Inc., an American producer of fragrances, biotech innovations, cosmetic actives, and organic health ingredients, released Aurist AGC, a novel biopolymer intended for hair care applications. This demonstrates the potential of the new DEB platform by harnessing IFF’s complete biotechnological capabilities to deliver enduring, high-performance glamour solutions that can genuinely drive transformation within the cosmeceutical sector. This ingredient utilizes IFF’s proprietary Designed Enzymatic Biopolymers (DEB) technology, an advanced biotechnological method capable of creating new bio-based polysaccharides featuring unique structures and product attributes.

Biotech Ingredient Market Key Companies And Competitive Benchmarking

Major companies operating in the biotech ingredient market are Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc.

Access The Complete Biotech Ingredient Market Report:

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Biotech Ingredient Market Largest Region By Revenue And Market Share

Europe was the largest region in the biotech ingredient market in 2025. Asia-Pacific is expected to be the fastest-growing region in the biotech ingredients market report during the forecast period. The regions covered in the biotech ingredient market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Market Value Of The Biotech Ingredient Market Projected To Expand During 2026–2030?

The biotech ingredient market has experienced robust growth in recent years. It is projected to expand from $63.25 billion in 2025 to $67.42 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 6.6%. This historical expansion can be attributed to factors such as a heightened demand for natural and safe ingredients, advancements in microbial fermentation technologies, increased awareness of biotech applications in food and personal care, a rising consumer preference for sustainable ingredients, and the early adoption of yeast- and algae-based compounds.

The biotech ingredient market is projected to experience substantial growth over the upcoming years. It is anticipated to reach $87.06 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.6%. This anticipated expansion is fueled by factors such as the widening scope of precision medicine and individualized nutrition, enhanced governmental backing for biotechnology research and development, the scaling up of microbial and yeast-based expression systems, the integration of artificial intelligence and automation in manufacturing processes, and its expanding utility across sectors like cosmetics, cleaning agents, and food production. Key developments expected during this timeframe encompass breakthroughs in synthetic biology, novel innovations in microbial engineering, the development of more economical methods for ingredient production, adherence to regulatory requirements and safety protocols, and further penetration into applications within the food, personal care, and cleaning product domains.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9817&type=smp

What Major Growth Factors Are Impacting The Biotech Ingredient Market?

The escalating demand for personal care products is anticipated to boost the growth of the biotech ingredient market moving forward. These products broadly cover items used for maintaining personal hygiene and improving one’s appearance. Biotech ingredients in personal care items provide advantages such as a diminished environmental footprint, sustainability, uniform quality, lower allergenic potential, biocompatibility, greater efficacy, and reduced reliance on petrochemicals. For example, in December 2024, the Bureau of Labor Statistics, a US-based government agency, reported that the average annual expenditure on personal care products and services increased from $866 per consumer unit in 2022 to $950 per consumer unit in 2023. Thus, the rising demand for personal care products is acting as a key driver for the expansion of the biotech ingredient market.

How Is The Biotech Ingredient Market Examined Through Segment Analysis?

The biotech ingredient market covered in this report is segmented –

1) By Type: Active Pharmaceutical Ingredients, Biosimilars

2) By Expression Systems: Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, Insect Expression Systems

3) By Application: Food And Beverages, Personal Care And Cosmetics, Cleaning Products, Other Applications

Subsegments:

1) By Active Pharmaceutical Ingredients (APIs): Biologic APIs, Synthetic APIs

2) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Insulin Biosimilars

Which Trends Are Affecting The Biotech Ingredient Market Framework?

Leading companies in the biotech ingredient market are concentrating on creating inventive solutions, like sophisticated biotechnology-derived ingredient platforms, to satisfy the increasing need for high-performing, sustainable, and cutting-edge cosmetic and personal care products. These ingredients, powered by biotechnology, utilize enzymatic and bio-based methods to form unique molecular structures that boast improved functionality, delivering superior performance, scalability, and ecological advantages over conventionally chemically synthesized ingredients. For example, in March 2023, International Flavors & Fragrances Inc., a US-based producer of fragrance, biotech solutions, cosmetic energetics, and organic health ingredients, introduced Aurist AGC, a new biopolymer designed for hair care. This demonstrates the new DEB platform’s capability, employing IFF’s extensive biotechnology expertise to provide durable and high-performing beauty solutions that can significantly drive innovation in the cosmeceutical sector. The ingredient incorporates IFF’s exclusive Designed Enzymatic Biopolymers (DEB) technology, an advanced biotechnological method able to generate new bio-based polysaccharides with unique structures and product characteristics.

Who Are The Prominent Players Across The Biotech Ingredient Market?

Major companies operating in the biotech ingredient market are Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc.

Access The Complete Biotech Ingredient Market Report:

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

Which Region Contributes The Most To The Biotech Ingredient Market?

Europe was the largest region in the biotech ingredient market in 2025. Asia-Pacific is expected to be the fastest-growing region in the biotech ingredients market report during the forecast period. The regions covered in the biotech ingredient market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Biotech Ingredient Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=9817&type=smp

Browse Through More Reports Similar to the Global Biotech Ingredient Market 2026, By The Business Research Company

Biotech Ingredient Market Report 2026

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

Bioactive Ingredients Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioactive-ingredients-global-market-report

Ingredients Market Report 2026

https://www.thebusinessresearchcompany.com/report/ingredients-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Biotech Ingredient Market During 2026–2030?

The biotech ingredient market has experienced significant growth in recent years. It is projected to increase from $63.25 billion in 2025 to $67.42 billion in 2026, representing a compound annual growth rate (CAGR) of 6.6%. This historical expansion can be attributed to an increasing demand for natural and safe ingredients, advances in microbial fermentation technologies, a growing awareness of biotech applications in food and personal care, rising consumer preference for sustainable ingredients, and the early adoption of yeast- and algae-based compounds.

The size of the biotech ingredient market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $87.06 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.6%. The projected growth during this period stems from several factors, including the expansion of precision medicine and personalized nutrition, augmented governmental backing for biotech research and development, the scaling up of microbial and yeast expression systems, the integration of AI and automation into production processes, and the expanding utilization across the cosmetics, cleaning products, and food sectors. Key trends expected during the forecast timeframe encompass progress in synthetic biology, novelties in microbial engineering, the development of economical ingredient manufacturing, adherence to regulatory compliance and safety standards, and broadening applications in food, personal care, and cleaning sectors.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9817&type=smp

What Key Factors Are Affecting The Biotech Ingredient Market Demand?

The rising demand for personal care products is projected to fuel the expansion of the biotech ingredient market. These products encompass a wide range of items used for personal hygiene and cosmetic enhancement. Biotech ingredients in personal care products contribute to a smaller environmental footprint, promote sustainability, ensure consistent quality, lower allergenic risks, improve biocompatibility, boost effectiveness, and lessen reliance on petrochemicals. For example, in December 2024, data from the Bureau of Labor Statistics, a US-based government agency, indicated that the average yearly spending on personal care products and services increased from $866 per consumer unit in 2022 to $950 per consumer unit in 2023. Consequently, this escalating demand for personal care products is a key driver for the growth of the biotech ingredient market.

How Are Segments Identified Within The Biotech Ingredient Market Segment Framework?

The biotech ingredient market covered in this report is segmented –

1) By Type: Active Pharmaceutical Ingredients, Biosimilars

2) By Expression Systems: Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, Insect Expression Systems

3) By Application: Food And Beverages, Personal Care And Cosmetics, Cleaning Products, Other Applications

Subsegments:

1) By Active Pharmaceutical Ingredients (APIs): Biologic APIs, Synthetic APIs

2) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Insulin Biosimilars

What Market Trends Are Affecting The Biotech Ingredient Market?

Major companies within the biotech ingredient market are focusing on the creation of innovative solutions, such as advanced biotechnology-based ingredient platforms, to address the increasing demand for high-performance, sustainable, and next-generation cosmetic and personal care formulations. These biotechnology-driven ingredients harness enzymatic and bio-based processes to form novel molecular structures with enhanced functionality, delivering superior performance, scalability, and environmental advantages compared to traditional chemically synthesized ingredients. For instance, in March 2023, International Flavors & Fragrances Inc., a US-based manufacturer of fragrance, biotech solutions, cosmetic energetics, and organic health ingredients, launched Aurist AGC, a novel biopolymer for hair care. This demonstrates the new DEB platform’s potential by utilizing IFF’s comprehensive biotechnology functionality to ensure sustained and high-performance glamour solutions that can genuinely contribute to change in the cosmeceutical industry. The ingredient employs IFF’s proprietary Designed Enzymatic Biopolymers (DEB) technology, an advanced biotechnology capable of producing novel bio-based polysaccharides with distinct structures and product features.

Who Are The Companies Competing Within The Biotech Ingredient Market?

Major companies operating in the biotech ingredient market are Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc.

Get The Full Biotech Ingredient Market Report:

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

Which Region Accounts For The Largest Portion Of The Biotech Ingredient Market?

Europe was the largest region in the biotech ingredient market in 2025. Asia-Pacific is expected to be the fastest-growing region in the biotech ingredients market report during the forecast period. The regions covered in the biotech ingredient market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Biotech Ingredient Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

Browse Through More Reports Similar to the Global Biotech Ingredient Market 2026, By The Business Research Company

Biotech Ingredient Market Report 2026

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

Bioactive Ingredients Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioactive-ingredients-global-market-report

Ingredients Market Report 2026

https://www.thebusinessresearchcompany.com/report/ingredients-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Biotech Ingredient Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The biotech ingredient market size has experienced robust growth in recent years. It is projected to expand from $63.25 billion in 2025 to $67.42 billion in 2026, at a compound annual growth rate (CAGR) of 6.6%. The historical period’s growth can be attributed to several factors, including an escalating demand for natural and safe ingredients, advancements in microbial fermentation technologies, increasing awareness of biotech applications in food and personal care, a rising consumer preference for sustainable ingredients, and the early adoption of yeast- and algae-based compounds.

The biotech ingredient market size is projected for robust expansion over the coming years, set to reach $87.06 billion by 2030 with a compound annual growth rate (CAGR) of 6.6%. This growth during the forecast period is attributed to the expansion of precision medicine and personalized nutrition, increased government support for biotech R&D, the scaling up of microbial and yeast expression systems, the adoption of AI and automation in production, and its growing application across cosmetics, cleaning products, and food industries. Significant trends during this period include advancements in synthetic biology, innovations in microbial engineering, the focus on cost-effective ingredient production, adherence to regulatory compliance and safety standards, and an expansion into food, personal care, and cleaning applications.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9817&type=smp

What Major Drivers Are Influencing Demand In The Biotech Ingredient Market?

The escalating need for personal care products is anticipated to drive the future expansion of the biotech ingredient market. Personal care products encompass a broad array of items used for maintaining personal cleanliness and enhancing one’s physical appearance. Biotech ingredients in these products offer benefits such as a reduced environmental footprint, enhanced sustainability, consistent quality, lower allergenic potential, biocompatibility, improved effectiveness, and decreased reliance on petrochemicals. For illustration, in December 2024, data from the Bureau of Labor Statistics, a US-based government agency, indicated that the average annual expenditure on personal care products and services saw an increase from $866 per consumer unit in 2022 to $950 per consumer unit in 2023. Hence, the rising consumer demand for personal care products is propelling the growth of the biotech ingredient market.

What Major Segment Divisions Exist Within The Biotech Ingredient Market?

The biotech ingredient market covered in this report is segmented –

1) By Type: Active Pharmaceutical Ingredients, Biosimilars

2) By Expression Systems: Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, Insect Expression Systems

3) By Application: Food And Beverages, Personal Care And Cosmetics, Cleaning Products, Other Applications

Subsegments:

1) By Active Pharmaceutical Ingredients (APIs): Biologic APIs, Synthetic APIs

2) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Insulin Biosimilars

How Are Trends Shaping The Direction Of The Biotech Ingredient Market?

Major companies in the biotech ingredient market are focused on creating innovative solutions, including advanced biotechnology-based ingredient platforms, to address the growing demand for high-performance, sustainable, and next-generation cosmetic and personal care formulations. These biotechnology-driven ingredients harness enzymatic and bio-based processes to generate novel molecular structures with enhanced functionality, delivering superior performance, scalability, and environmental benefits compared to traditional chemically synthesized ingredients. For instance, in March 2023, International Flavors & Fragrances Inc., a US-based manufacturer specializing in fragrance, biotech solutions, cosmetic energetics, and organic health ingredients, introduced Aurist AGC, a new biopolymer for hair care. This exemplifies the potential of the new DEB platform by leveraging IFF’s comprehensive biotechnology capabilities to ensure sustained and high-performance glamour solutions that can truly bring about change in the cosmeceutical industry. The ingredient itself employs IFF’s proprietary Designed Enzymatic Biopolymers (DEB) technology, an advanced biotechnology capable of producing novel bio-based polysaccharides with distinct structures and product features.

Which Companies Are Leading Innovation In The Biotech Ingredient Market?

Major companies operating in the biotech ingredient market are Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc.

Read the full biotech ingredient market report here:

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Biotech Ingredient Market?

Europe was the largest region in the biotech ingredient market in 2025. Asia-Pacific is expected to be the fastest-growing region in the biotech ingredients market report during the forecast period. The regions covered in the biotech ingredient market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biotech Ingredient Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9817&type=smp

Browse Through More Reports Similar to the Global Biotech Ingredient Market 2026, By The Business Research Company

Biotech Ingredient Market Report 2026

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

Bioactive Ingredients Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioactive-ingredients-global-market-report

Ingredients Market Report 2026

https://www.thebusinessresearchcompany.com/report/ingredients-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the biotech ingredient market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Biotech Ingredient Market?

In recent years, the biotech ingredient market has experienced robust expansion. It is forecast to increase from $63.25 billion in 2025 to $67.42 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.6%. The historical growth of this market can be linked to several factors, including a heightened demand for natural and secure ingredients, advancements in microbial fermentation technologies, a growing understanding of biotech applications in the food and personal care industries, an escalating consumer inclination towards sustainable ingredients, and the initial integration of yeast- and algae-based compounds.

The biotech ingredient market is projected to experience robust expansion over the coming years. Its valuation is set to reach $87.06 billion by 2030, driven by a compound annual growth rate (CAGR) of 6.6%. This anticipated growth is largely due to factors such as the widening scope of precision medicine and personalized nutrition, enhanced governmental backing for biotech research and development, the scaling up of microbial and yeast expression systems, the integration of AI and automation in manufacturing processes, and the increasing uses across the cosmetics, cleaning product, and food sectors. Key developments expected during this period encompass progress in synthetic biology, breakthroughs in microbial engineering, the pursuit of more economical ingredient production, stringent regulatory adherence and safety benchmarks, and a broader uptake in food, personal care, and cleaning uses.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9817&type=smp

What Drivers Are Supporting Technological Adoption In The Biotech Ingredient Market?

The rising consumer need for personal care products is projected to stimulate the expansion of the biotech ingredient market moving forward. Personal care products encompass a broad array of goods utilized for maintaining individual hygiene and enhancing one’s appearance. Biotech components in these products offer advantages such as a diminished environmental impact, sustainability, consistent quality, reduced potential for allergies, biocompatibility, improved effectiveness, and less reliance on petrochemicals. For illustration, the Bureau of Labor Statistics, a US-based government agency, indicated in December 2024 that the average yearly spending on personal care products and services per consumer unit climbed from $866 in 2022 to $950 in 2023. This demonstrates how the heightened demand for personal care products is powering the growth of the biotech ingredient market.

What Segment Types Are Examined In The Biotech Ingredient Market?

The biotech ingredient market covered in this report is segmented –

1) By Type: Active Pharmaceutical Ingredients, Biosimilars

2) By Expression Systems: Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, Insect Expression Systems

3) By Application: Food And Beverages, Personal Care And Cosmetics, Cleaning Products, Other Applications

Subsegments:

1) By Active Pharmaceutical Ingredients (APIs): Biologic APIs, Synthetic APIs

2) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Insulin Biosimilars

How Are New Market Trends Shaping The Landscape Of The Biotech Ingredient Market?

Leading companies in the biotech ingredient market are concentrating on developing innovative solutions, including advanced biotechnology-based ingredient platforms. This effort is driven by the increasing demand for high-performance, sustainable, and next-generation cosmetic and personal care formulations. These biotechnology-driven ingredients harness enzymatic and bio-based processes to create novel molecular structures with enhanced functionality, offering superior performance, scalability, and environmental advantages over traditional chemically synthesized ingredients. For instance, in March 2023, International Flavors & Fragrances Inc., a US-based manufacturer of fragrance, biotech solutions, cosmetic energetics, and organic health ingredients, launched Aurist AGC, a new biopolymer for hair care. This product demonstrates the potential of the new DEB platform, leveraging IFF’s extensive biotechnology functionality to ensure sustained and high-performance glamour solutions that can genuinely contribute to change in the cosmeceutical industry. The ingredient incorporates IFF’s proprietary Designed Enzymatic Biopolymers (DEB) technology, an advanced biotechnology capable of producing novel bio-based polysaccharides with distinct structures and product features.

Who Are The Core Companies Influencing Trends In The Biotech Ingredient Market?

Major companies operating in the biotech ingredient market are Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

Which Regions Are Projected To Dominate The Biotech Ingredient Market In The Coming Years?

Europe was the largest region in the biotech ingredient market in 2025. Asia-Pacific is expected to be the fastest-growing region in the biotech ingredients market report during the forecast period. The regions covered in the biotech ingredient market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Biotech Ingredient Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9817&type=smp

Browse Through More Reports Similar to the Global Biotech Ingredient Market 2026, By The Business Research Company

Biotech Ingredient Market Report 2026

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

Bioactive Ingredients Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioactive-ingredients-global-market-report

Ingredients Market Report 2026

https://www.thebusinessresearchcompany.com/report/ingredients-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the biotech ingredient market from 2025–2034 with trusted insights from The Business Research Company

What Is The Current Size And Expected Growth Outlook For The Biotech Ingredient Market?

The biotech ingredient market size has seen strong growth in recent years. It is forecast to expand from $59.9 billion in 2024 to $63.25 billion in 2025, progressing at a compound annual growth rate (CAGR) of 5.6%. This historical expansion can be linked to innovations within the food and beverage industry, the rising adoption of biofuel, consumer demand for functional foods, and breakthroughs in genetic engineering.

The biotech ingredient market size is expected to show robust growth in the upcoming years. It is projected to reach $81.66 billion by 2029, achieving a compound annual growth rate (CAGR) of 6.6%. The expansion during the forecast period is driven by a focus on personalized nutrition, the growth of cell-based meat production, advancements in therapeutic biotech ingredients, the utilization of bio ingredients for waste reduction, and a general move towards bioplastics. Significant trends for the forecast period include biotech-based functional foods, biotech solutions for circular economy practices, the continued development of therapeutic biotech ingredients, biotech ingredients for clean energy production, and a global emphasis on biodiversity conservation.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9817&type=smp

Which Growth Drivers Are Propelling The Biotech Ingredient Market?

The increasing demand for generic drugs is anticipated to propel the expansion of the biotech ingredient market in the future. A generic medicine is defined as a pharmaceutical product designed to possess the same characteristics as a previously approved medication. Biotech ingredients are utilized in general medicine as they serve as a key source for delivering more economical and effective methods of producing various active ingredients that are almost identical to the original item, typically governed by an extended set of regulations. For instance, according to the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, the endorsement of 12 new personalized medicines constituted about 34% of all recently approved therapies, demonstrating a significant increase compared to preceding years. Therefore, the escalating demand for generic medicines is driving the growth of the biotech ingredient market.

Which Segmentation Factors Are Most Significant In The Biotech Ingredient Market Analysis?

The biotech ingredient market covered in this report is segmented –

1) By Type: Active Pharmaceutical Ingredients, Biosimilars

2) By Expression Systems: Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, Insect Expression Systems

3) By Application: Food And Beverages, Personal Care And Cosmetics, Cleaning Products, Other Applications

Subsegments:

1) By Active Pharmaceutical Ingredients (APIs): Biologic APIs, Synthetic APIs

2) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Insulin Biosimilars

What New Opportunities Are Emerging From Trends In The Biotech Ingredient Market?

Technological advancement has emerged as the primary trend gaining popularity in the biotech ingredient market. Major companies operating in this sector are introducing new technologies to develop innovative products, aiming to strengthen their market position. For instance, in March 2023, International Flavors & Fragrances Inc., a US-based manufacturer specializing in fragrance, biotech solutions, cosmetic energetics, and organic health ingredients, launched Aurist AGC, a novel biopolymer designed for hair care. This showcases the potential of the new DEB platform by leveraging IFF’s comprehensive biotechnology functionality to ensure sustained and high-performance glamour solutions that can genuinely contribute to change within the cosmeceutical industry. The ingredient incorporates IFF’s proprietary Designed Enzymatic Biopolymers (DEB) technology, an advanced biotechnology capable of producing novel biobased polysaccharides with distinct structures and product features.

Who Are The Most Influential Companies In The Biotech Ingredient Market?

Major companies operating in the biotech ingredient market include Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

Which Region Holds The Largest Share In The Biotech Ingredient Market Today?

Europe was the largest region in the biotech ingredient market in 2024. Asia-Pacific is expected to be the fastest-growing region in the biotech ingredients market report during the forecast period. The regions covered in the biotech ingredient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=9817&type=smp

Browse Through More Reports Similar to the Global Biotech Ingredient Market 2025, By The Business Research Company

Composites Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/composites-global-market-report

Ceramic Matrix Composites Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ceramic-matrix-composites-global-market-report

Bioadhesives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bioadhesives-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Future Market Size Estimation For The Biotech Ingredient Market Covering 2025–2034?

The biotech ingredient market has shown significant expansion in recent years. Its valuation is set to rise from $59.9 billion in 2024 to $63.25 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.6%. This historical development can be credited to advancements in the food and beverage industry, the growing utilization of biofuel, heightened consumer interest in functional foods, and breakthroughs in genetic engineering.

The biotech ingredient market is projected to experience substantial expansion over the coming years. By 2029, its valuation is anticipated to reach $81.66 billion, exhibiting a compound annual growth rate (CAGR) of 6.6%. This projected growth during the forecast period stems from factors such as a heightened focus on personalized nutrition, the increased expansion of cell-based meat production, advancements in the development of therapeutic biotech ingredients, the utilization of bio ingredients for waste reduction, and a general shift towards bioplastics. Key trends identified for this period encompass biotech-based functional foods, the adoption of biotech solutions for circular economy practices, the advancement of therapeutic biotech ingredients, the development of biotech ingredients for clean energy production, and a worldwide emphasis on biodiversity conservation.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9817&type=smp

What Are The Key Drivers Of Growth In The Biotech Ingredient Market?

The increasing demand for generic medicines is anticipated to boost the growth of the biotech ingredient market in the future. A generic medicine is defined as a drug formulated to possess the same characteristics as a previously approved medication. Biotech ingredients are employed in general medicine as they represent the primary method for delivering more cost-effective and efficient ways to manufacture a variety of active ingredients that are nearly identical to the original product and are typically governed by a comprehensive set of regulations. For instance, according to the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, the approval of 12 new personalized medicines accounted for about 34% of all newly approved therapies, indicating a substantial rise compared to earlier years. Thus, the escalating demand for generic medicines is propelling the expansion of the biotech ingredient market.

What Are The Primary Types Of Segments Analyzed In The Biotech Ingredient Market?

The biotech ingredient market covered in this report is segmented –

1) By Type: Active Pharmaceutical Ingredients, Biosimilars

2) By Expression Systems: Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, Insect Expression Systems

3) By Application: Food And Beverages, Personal Care And Cosmetics, Cleaning Products, Other Applications

Subsegments:

1) By Active Pharmaceutical Ingredients (APIs): Biologic APIs, Synthetic APIs

2) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Insulin Biosimilars

Which Competitive Trends Are Defining The Biotech Ingredient Market Structure?

Technological advancement has become the leading trend gaining popularity within the biotech ingredient market. Major companies operating in this market are introducing new technologies to develop innovative products, thereby strengthening their position. For example, in March 2023, International Flavors & Fragrances Inc., a US-based manufacturer of fragrance, biotech solutions, cosmetic energetics, and organic health ingredients, launched Aurist AGC, a novel biopolymer for hair care. This demonstrates the new DEB platform’s potential by leveraging IFF’s extensive biotechnology functionality to ensure sustained, high-performance glamour solutions that can genuinely contribute to transformation in the cosmeceutical industry. The ingredient utilizes IFF’s proprietary Designed Enzymatic Biopolymers (DEB) technology, an advanced biotechnology capable of producing novel biobased polysaccharides with distinct structures and product features.

Who Are The Top Performing Companies In The Biotech Ingredient Market In Recent Years?

Major companies operating in the biotech ingredient market include Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

How Do Regional Market Performances Compare Within The Biotech Ingredient Industry?

Europe was the largest region in the biotech ingredient market in 2024. Asia-Pacific is expected to be the fastest-growing region in the biotech ingredients market report during the forecast period. The regions covered in the biotech ingredient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Biotech Ingredient Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9817&type=smp

Browse Through More Reports Similar to the Global Biotech Ingredient Market 2025, By The Business Research Company

Composites Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/composites-global-market-report

Ceramic Matrix Composites Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ceramic-matrix-composites-global-market-report

Bioadhesives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bioadhesives-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Big Is The Biotech Ingredient Market Today And What Is Its Future Size?

In recent times, the biotech ingredient market has experienced robust growth. The market which stood at $59.9 billion in 2024, is projected to rise to $63.25 billion in 2025, marking a compound annual growth rate (CAGR) of 5.6%. Factors contributing to this growth during the historic period include advances in the food and beverage industry, wider acceptance of biofuel, a rising demand for functional foods among consumers, and breakthroughs in genetic engineering.

In the ensuing years, the biotech ingredient market is anticipated to experience robust growth, reaching “$81.66 billion in 2029 with a compound annual growth rate (CAGR) of 6.6%. This surging growth within the predicted period can be ascribed to a concentration on tailored nutrition, the rise of cell-based meat manufacturing, the creation of therapeutic biotech ingredients, bio ingredients to mitigate waste, and a shift towards bioplastics. In the coming future, significant tendencies will entail functional foods based on biotech, biotech solutions geared towards circular economy approaches, therapeutic biotech ingredients, biotech ingredients contributing to clean energy production, and a worldwide stress on preserving biodiversity.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9817&type=smp

Which Industry Forces Are Driving The Biotech Ingredient Market Forward?

The burgeoning need for generic medications is anticipated to stimulate the biotech ingredient market’s expansion. Generic drugs are those designed to emulate the properties of a previously sanctioned drug. Biotech ingredients play a crucial role in general medicine, serving as a more affordable and efficient method of producing a variety of active ingredients nearly identical to the original product. These ingredients are generally governed by a comprehensive set of rules. The Personalized Medicine Coalition, a professional group based in the US, indicated that in 2022, the sanctioning of 12 new personalized medicines constituted approximately 34% of all fresh therapeutic approvals, a pronounced increase from preceding years. As a result, the growing requirement for generic drugs is propelling the biotech ingredient market’s growth.

How Is The Global Biotech Ingredient Market Broken Down By Segment?

The biotech ingredient market covered in this report is segmented –

1) By Type: Active Pharmaceutical Ingredients, Biosimilars

2) By Expression Systems: Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, Insect Expression Systems

3) By Application: Food And Beverages, Personal Care And Cosmetics, Cleaning Products, Other Applications

Subsegments:

1) By Active Pharmaceutical Ingredients (APIs): Biologic APIs, Synthetic APIs

2) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Insulin Biosimilars

Which Trends Are Likely To Redefine Growth Paths In The Biotech Ingredient Market?

The technology revolution is becoming a prominent trend in the biotechnological ingredient sector. Leading firms are employing innovative tech to create new products and establish market dominance in the biotech ingredient industry. For example, International Flavors & Fragrances Inc., an American outfit known for producing fragrance, biotechnological solutions, cosmetic energetics, and organic health constituents, unveiled Aurist AGC, an innovative biopolymer specifically for haircare, in March 2023. This underscores the extensive capabilities of IFF’s new DEB platform, leveraging comprehensive biotech functions to deliver long-lasting, high-performance glamour solutions that indeed have the potential to bring about change in the cosmeceutical industry. The key component utilizes IFF’s exclusive DEB (Designed Enzymatic Biopolymers) technology, a sophisticated biotech solution capable of generating unique bio-based polysaccharides with special structures and product features.

Who Are The Most Influential Companies In The Biotech Ingredient Market?

Major companies operating in the biotech ingredient market include Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Biotech Ingredient Market?

Europe was the largest region in the biotech ingredient market in 2024. Asia-Pacific is expected to be the fastest-growing region in the biotech ingredients market report during the forecast period. The regions covered in the biotech ingredient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=9817&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Big Is The Biotech Ingredient Market Today And What Is Its Future Size?

In recent times, the biotech ingredient market has experienced robust growth. The market which stood at $59.9 billion in 2024, is projected to rise to $63.25 billion in 2025, marking a compound annual growth rate (CAGR) of 5.6%. Factors contributing to this growth during the historic period include advances in the food and beverage industry, wider acceptance of biofuel, a rising demand for functional foods among consumers, and breakthroughs in genetic engineering.

In the ensuing years, the biotech ingredient market is anticipated to experience robust growth, reaching “$81.66 billion in 2029 with a compound annual growth rate (CAGR) of 6.6%. This surging growth within the predicted period can be ascribed to a concentration on tailored nutrition, the rise of cell-based meat manufacturing, the creation of therapeutic biotech ingredients, bio ingredients to mitigate waste, and a shift towards bioplastics. In the coming future, significant tendencies will entail functional foods based on biotech, biotech solutions geared towards circular economy approaches, therapeutic biotech ingredients, biotech ingredients contributing to clean energy production, and a worldwide stress on preserving biodiversity.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9817&type=smp

Which Industry Forces Are Driving The Biotech Ingredient Market Forward?

The burgeoning need for generic medications is anticipated to stimulate the biotech ingredient market’s expansion. Generic drugs are those designed to emulate the properties of a previously sanctioned drug. Biotech ingredients play a crucial role in general medicine, serving as a more affordable and efficient method of producing a variety of active ingredients nearly identical to the original product. These ingredients are generally governed by a comprehensive set of rules. The Personalized Medicine Coalition, a professional group based in the US, indicated that in 2022, the sanctioning of 12 new personalized medicines constituted approximately 34% of all fresh therapeutic approvals, a pronounced increase from preceding years. As a result, the growing requirement for generic drugs is propelling the biotech ingredient market’s growth.

How Is The Global Biotech Ingredient Market Broken Down By Segment?

The biotech ingredient market covered in this report is segmented –

1) By Type: Active Pharmaceutical Ingredients, Biosimilars

2) By Expression Systems: Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, Insect Expression Systems

3) By Application: Food And Beverages, Personal Care And Cosmetics, Cleaning Products, Other Applications

Subsegments:

1) By Active Pharmaceutical Ingredients (APIs): Biologic APIs, Synthetic APIs

2) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Insulin Biosimilars

Which Trends Are Likely To Redefine Growth Paths In The Biotech Ingredient Market?

The technology revolution is becoming a prominent trend in the biotechnological ingredient sector. Leading firms are employing innovative tech to create new products and establish market dominance in the biotech ingredient industry. For example, International Flavors & Fragrances Inc., an American outfit known for producing fragrance, biotechnological solutions, cosmetic energetics, and organic health constituents, unveiled Aurist AGC, an innovative biopolymer specifically for haircare, in March 2023. This underscores the extensive capabilities of IFF’s new DEB platform, leveraging comprehensive biotech functions to deliver long-lasting, high-performance glamour solutions that indeed have the potential to bring about change in the cosmeceutical industry. The key component utilizes IFF’s exclusive DEB (Designed Enzymatic Biopolymers) technology, a sophisticated biotech solution capable of generating unique bio-based polysaccharides with special structures and product features.

Who Are The Most Influential Companies In The Biotech Ingredient Market?

Major companies operating in the biotech ingredient market include Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Biotech Ingredient Market?

Europe was the largest region in the biotech ingredient market in 2024. Asia-Pacific is expected to be the fastest-growing region in the biotech ingredients market report during the forecast period. The regions covered in the biotech ingredient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=9817&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model